Revisions for Ciprofloxacin

Revisions allow you to track differences between multiple versions of your content, and revert back to older versions.

RevisionOperations
05-8-24 by ripal121current revision
04-25-24 by kaipe
04-24-24 by ripal121
04-24-24 by ripal121
07-23-21 by conan.macdougal...
06-24-21 by conan.macdougal...
05-12-21 by [email protected]
05-6-21 by [email protected]
08-12-20 by conan.macdougal...
08-12-20 by conan.macdougal...
08-12-20 by conan.macdougal...
08-12-20 by conan.macdougal...
08-12-20 by conan.macdougal...
07-10-20 by [email protected]
07-7-20 by [email protected]
07-7-20 by [email protected]
04-17-20 by ucsf_admin

Dosing: Adult Antimicrobial Dosing, Non-dialysis

Indication CrCl > 50 mL/min 30 - 50 mL/min < 30 mL/min
 

400 mg IV q12h

500 mg PO BID

400 mg IV q12h

500 mg PO BID

400 mg IV q24h

500 mg PO daily

Pseudomonas infections, bloodstream infections, & induction therapy for
Staphylococcus hardware infections +/- rifampin

400 mg IV q8h

750 mg PO q12h

400 mg IV q12h

500 mg PO q12h

400 mg IV q24h

500 mg PO daily

Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis

Indication

Intermittent Hemodialysis

Continuous Hemodialysis
All Indications 400 mg IV qPM or 500 mg PO qPM 400 mg IV q8h or 500 mg PO q12h

Dialysis Notes

Intermittent HD assumes high-flux hemodialysis. CRRT assumes CVVHD with ultrafiltration rate 2L/h and residual native GFR < 10 mL/min.  For detailed view of dialysis dosing and evidence, see Dosing in Hemodialysis document.

References: